Published : 04 May 2016

---

Aagami has signed up with another new client in the US. Client has a unique technology to delivery technology, which bypasses the Blood Brain Barrier (BBB) enabling drugs to reach the brain, hence enabling next-generation therapeutics for CNS disorders.

They also have a strong pipeline of assets which leverages this technology

Client has appointed Aagami to help them out license the technology and /or the pipeline assets. Once again, Aagami is excited to take client offerings to India based global companies who are cash rich, have world class infrastructure and are hungry to compete with the best in the World.